Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Maurizio Fava

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Drug Resistance

Activities & Behaviors

Questionnaires

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Iosifescu Dan V; Greenwald Scott; Devlin Philip; Mischoulon David; Denninger John W; Alpert Jonathan E; Fava Maurizio
Frontal EEG predictors of treatment outcome in major depressive disorder.
Kashner T Michael; Trivedi Madhukar H; Wicker Annie; Fava Maurizio; Shores-Wilson Kathy; Wisniewski Stephen R; Rush A John
Release bias in accessing medical records in clinical trials: a STAR*D report.
Rush A John; Warden Diane; Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Gaynes Bradley N; Nierenberg Andrew A
STAR*D: revising conventional wisdom.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Maurizio Fava (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Iosifescu Dan V; Greenwald Scott; Devlin Philip; Mischoulon David; Denninger John W; Alpert Jonathan E; Fava Maurizio
Frontal EEG predictors of treatment outcome in major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(11):772-7.
2009: Kashner T Michael; Trivedi Madhukar H; Wicker Annie; Fava Maurizio; Shores-Wilson Kathy; Wisniewski Stephen R; Rush A John
Release bias in accessing medical records in clinical trials: a STAR*D report.
International journal of methods in psychiatric research 2009;18(3):147-58.
2009: Rush A John; Warden Diane; Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Gaynes Bradley N; Nierenberg Andrew A
STAR*D: revising conventional wisdom.
CNS drugs 2009;23(8):627-47.
2009: Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Baker Ross A; Tran Quynh-Van; Pikalov Andrei; Yang Huyuan; Marcus Ronald N; Berman Robert M
Metabolic assessment of aripiprazole as adjunctive therapy in major depressive disorder: a pooled analysis of 2 studies.
Journal of clinical psychopharmacology 2009;29(4):362-7.
2009: Kaufman Marc J; Prescot Andrew P; Ongur Dost; Evins A Eden; Barros Tanya L; Medeiros Carissa L; Covell Julie; Wang Liqun; Fava Maurizio; Renshaw Perry F
Oral glycine administration increases brain glycine/creatine ratios in men: a proton magnetic resonance spectroscopy study.
Psychiatry research 2009;173(2):143-9.
2009: Fava Maurizio
Partial responders to antidepressant treatment: switching strategies.
The Journal of clinical psychiatry 2009;70(7):e24.
2009: Fava Maurizio; Asnis Gregory M; Shrivastava Ram; Lydiard Bruce; Bastani Bijan; Sheehan David; Roth Thomas
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Journal of clinical psychopharmacology 2009;29(3):222-30.
2009: Perlis Roy H; Laje Gonzalo; Smoller Jordan W; Fava Maurizio; Rush A John; McMahon Francis J
Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(7):1819-28.
2009: Yeung Albert; Johnson Daniel P; Trinh Nhi-Ha; Weng Wan-Chen Claire; Kvedar Joseph; Fava Maurizio
Feasibility and effectiveness of telepsychiatry services for chinese immigrants in a nursing home.
Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2009;15(4):336-41.
2009: Wisniewski Stephen R; Rush A John; Nierenberg Andrew A; Gaynes Bradley N; Warden Diane; Luther James F; McGrath Patrick J; Lavori Philip W; Thase Michael E; Fava Maurizio; Trivedi Madhukar H
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
The American journal of psychiatry 2009;166(5):599-607.
2009: Weiss Anthony P; Guidi Jenny; Fava Maurizio
Closing the efficacy-effectiveness gap: translating both the what and the how from randomized controlled trials to clinical practice.
The Journal of clinical psychiatry 2009;70(4):446-9.
2009: Perlis R H; Fava M; Trivedi M H; Alpert J; Luther J F; Wisniewski S R; Rush A John
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder.
Acta psychiatrica Scandinavica 2009;119(4):282-9.
2009: Kashner T Michael; Trivedi Madhukar H; Wicker Annie; Fava Maurizio; Greist John H; Mundt James C; Shores-Wilson Kathy; Rush A John; Wisniewski Stephen R
Voice response system to measure healthcare costs: a STAR*D report.
The American journal of managed care 2009;15(3):153-62.
2009: Husain Mustafa M; Rush A John; Wisniewski Stephen R; McClintock Shawn M; Fava Maurizio; Nierenberg Andrew A; Davis Lori; Balasubramani G K; Young Elizabeth; Albala A Ari; Trivedi Madhukar H
Family history of depression and therapeutic outcome: findings from STAR*D.
The Journal of clinical psychiatry 2009;70(2):185-95.
2009: Matthews John D; Siefert Caleb; Dording Christina; Denninger John W; Park Lawrence; van Nieuwenhuizen Adrienne O; Sklarsky Katherine; Hilliker Sarah; Homberger Caitlin; Rooney Kathryn; Fava Maurizio
An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Journal of clinical psychopharmacology 2009;29(1):73-6.
2009: Papakostas George I; Cooper-Kazaz Rena; Appelhof Bente C; Posternak Michael A; Johnson Daniel P; Klibanski Anne; Lerer Bernard; Fava Maurizio
Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.
International clinical psychopharmacology 2009;24(1):19-25.
2009: Howland Robert H; Rush A John; Wisniewski Stephen R; Trivedi Madhukar H; Warden Diane; Fava Maurizio; Davis Lori L; Balasubramani G K; McGrath Patrick J; Berman Susan R
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Drug and alcohol dependence 2009;99(1-3):248-60.
2009: Papakostas George I; Fava Maurizio
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(1):34-40.
2009: Warden Diane; Trivedi Madhukar H; Wisniewski Stephen R; Lesser Ira M; Mitchell Jeff; Balasubramani G K; Fava Maurizio; Shores-Wilson Kathy; Stegman Diane; Rush A John
Identifying risk for attrition during treatment for depression.
Psychotherapy and psychosomatics 2009;78(6):372-9.
2009: Kashner T Michael; Trivedi Madhukar H; Wicker Annie; Fava Maurizio; Wisniewski Stephen R; Rush A John
The impact of nonclinical factors on care use for patients with depression: a STAR*D report.
CNS neuroscience & therapeutics 2009;15(4):320-32.
2009: Friedman Edward S; Wisniewski Stephen R; Gilmer William; Nierenberg Andrew A; Rush A John; Fava Maurizio; Zisook Sidney; Balasubramani G K; Trivedi Madhukar H
Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
Depression and anxiety 2009;26(7):612-21.
2009: Morris David W; Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R; Balasubramani G K; Khan Ahsan Y; Jain Shailesh; Rush A John
Diurnal mood variation in outpatients with major depressive disorder.
Depression and anxiety 2009;26(9):851-63.
2009: Fava Maurizio; Iosifescu Dan V; Pedrelli Paola; Baer Lee
Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.
Psychotherapy and psychosomatics 2009;78(2):91-7.
2008: McGrath Patrick J; Khan Ahsan Y; Trivedi Madhukar H; Stewart Jonathan W; Morris David W; Wisniewski Stephen R; Miyahara Sachiko; Nierenberg Andrew A; Fava Maurizio; Rush John A
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
The Journal of clinical psychiatry 2008;69(12):1847-55.
2008: Evins A Eden; Culhane Melissa A; Alpert Jonathan E; Pava Joel; Liese Bruce S; Farabaugh Amy; Fava Maurizio
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Journal of clinical psychopharmacology 2008;28(6):660-6.
2008: Pedrelli Paola; Feldman Greg C; Vorono Sienna; Fava Maurizio; Petersen Timothy
Dysfunctional attitudes and perceived stress predict depressive symptoms severity following antidepressant treatment in patients with chronic depression.
Psychiatry research 2008;161(3):302-8.
2008: Papakostas G I; Homberger C H; Fava M
A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Journal of psychopharmacology (Oxford, England) 2008;22(8):843-8.
2008: Perlis Roy H; Moorjani Priya; Fagerness Jesen; Purcell Shaun; Trivedi Madhukar H; Fava Maurizio; Rush A John; Smoller Jordan W
Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2810-9.
2008: Howland Robert H; Wilson Michael G; Kornstein Susan G; Clayton Anita H; Trivedi Madhukar H; Wohlreich Madelaine M; Fava Maurizio
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2008;20(4):209-18.
2008: Makris Nikos; Gasic Gregory P; Kennedy David N; Hodge Steven M; Kaiser Jonathan R; Lee Myung Joo; Kim Byoung Woo; Blood Anne J; Evins A Eden; Seidman Larry J; Iosifescu Dan V; Lee Sang; Baxter Claudia; Perlis Roy H; Smoller Jordan W; Fava Maurizio; Breiter Hans C
Cortical thickness abnormalities in cocaine addiction--a reflection of both drug use and a pre-existing disposition to drug abuse?
Neuron 2008;60(1):174-88.
2008: Papakostas George I; McGrath Patrick; Stewart Jonathan; Charles Dana; Chen Ying; Mischoulon David; Dording Christina; Fava Maurizio
Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder.
Psychiatry research 2008;161(1):116-20.
2008: Mischoulon David; Fava Maurizio
Are nutritional supplements ready for prime time?
The Journal of clinical psychiatry 2008;69(9):1497-8.
2008: Mischoulon David; Best-Popescu Catherine; Laposata Michael; Merens Wendelien; Murakami Jessica L; Wu Shirley L; Papakostas George I; Dording Christina M; Sonawalla Shamsah B; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(9):639-45.
2008: Perlis Roy H; Holt Daphne J; Smoller Jordan W; Blood Anne J; Lee Sang; Kim Byoung Woo; Lee Myung Joo; Sun Mei; Makris Nikos; Kennedy David K; Rooney Kathryn; Dougherty Darin D; Hoge Rick; Rosenbaum Jerrold F; Fava Maurizio; Gusella James; Gasic Gregory P; Breiter Hans C;
Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants.
Archives of general psychiatry 2008;65(8):882-92.
2008: Rush A John; Wisniewski Stephen R; Warden Diane; Luther James F; Davis Lori L; Fava Maurizio; Nierenberg Andrew A; Trivedi Madhukar H
Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.
Archives of general psychiatry 2008;65(8):870-80.
2008: Papakostas George I; Stahl Stephen M; Krishen Alok; Seifert Cheryl A; Tucker Vivian L; Goodale Elizabeth P; Fava Maurizio
Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
The Journal of clinical psychiatry 2008;69(8):1287-92.
2008: Candrian Michele; Schwartz Faye; Farabaugh Amy; Perlis Roy H; Ehlert Ulrike; Fava Maurizio
Personality disorders and perceived stress in major depressive disorder.
Psychiatry research 2008;160(2):184-91.
2008: Iosifescu Dan V; Bolo Nicolas R; Nierenberg Andrew A; Jensen J Eric; Fava Maurizio; Renshaw Perry F
Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
Biological psychiatry 2008;63(12):1127-34.
2008: Matthews John D; Blais Mark; Park Lawrence; Welch Charles; Baity Matthew; Murakami Jessica; Sklarsky Katherine; Homberger Caitlin; Fava Maurizio
The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
Journal of psychiatric research 2008;42(7):526-31.
2008: Nierenberg Andrew A; Ostacher Michael J; Huffman Jeffrey C; Ametrano Rebecca M; Fava Maurizio; Perlis Roy H
A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2008;50(4):428-36.
2008: Iosifescu D V; Greenwald S; Devlin P; Perlis R H; Denninger J W; Alpert J E; Fava M
Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder.
Acta psychiatrica Scandinavica 2008;117(4):271-6.
2008: Papakostas George I; Fava Maurizio; Thase Michael E
Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches.
Biological psychiatry 2008;63(7):699-704.
2008: Yeung Albert; Fung Freddy; Yu Shu-Ching; Vorono Sienna; Ly Mary; Wu Shirley; Fava Maurizio
Validation of the Patient Health Questionnaire-9 for depression screening among Chinese Americans.
Comprehensive psychiatry 2008;49(2):211-7.
2008: Fava Maurizio; Rush A John; Alpert Jonathan E; Balasubramani G K; Wisniewski Stephen R; Carmin Cheryl N; Biggs Melanie M; Zisook Sidney; Leuchter Andrew; Howland Robert; Warden Diane; Trivedi Madhukar H
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
The American journal of psychiatry 2008;165(3):342-51.
2008: Simon N M; McNamara K; Chow C W; Maser R S; Papakostas G I; Pollack M H; Nierenberg A A; Fava M; Wong K K
A detailed examination of cytokine abnormalities in Major Depressive Disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(3):230-3.
2008: Harley Rebecca; Sprich Susan; Safren Steven; Jacobo Michelle; Fava Maurizio
Adaptation of dialectical behavior therapy skills training group for treatment-resistant depression.
The Journal of nervous and mental disease 2008;196(2):136-43.
2008: Kozel F Andrew; Trivedi Madhukar H; Wisniewski Stephen R; Miyahara Sachiko; Husain Mustafa M; Fava Maurizio; Lebowitz Barry; Zisook Sidney; Rush A John
Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(1):58-64.
2008: Dording Christina M; Fisher Lauren; Papakostas George; Farabaugh Amy; Sonawalla Shamsah; Fava Maurizio; Mischoulon David
A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction.
CNS neuroscience & therapeutics 2008;14(3):182-91.
2008: Targum Steven D; Pollack Mark H; Fava Maurizio
Redefining affective disorders: relevance for drug development.
CNS neuroscience & therapeutics 2008;14(1):2-9.
2008: Petersen Timothy; Perlis Roy H; Ticknor Chris; Lohr Jim; Solvason H Brent; O'Reardon John P; Wohlreich Madelaine M; Andreotti Charissa; Wilson Michael; Fava Maurizio
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.
Psychopharmacology bulletin 2008;41(1):34-45.
2008: Russell James M; Weisberg Risa; Fava Maurizio; Hartford James T; Erickson Janelle S; D'Souza Deborah N
Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Depression and anxiety 2008;25(7):E1-11.
2007: Warden Diane; Rush A John; Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R
The STAR*D Project results: a comprehensive review of findings.
Current psychiatry reports 2007;9(6):449-59.
2007: Papakostas George I; Thase Michael E; Fava Maurizio; Nelson J Craig; Shelton Richard C
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
Biological psychiatry 2007;62(11):1217-27.
2007: Yeung Albert; Mischoulon David; Alpert Jonathan; Ma Yantao; Fava Maurizio
Acupuncture for major depressive disorder: has its efficacy been disproved?
The Journal of clinical psychiatry 2007;68(10):1617; author reply 1617-8.
2007: Papakostas George I; Fava Maurizio
A meta-analysis of clinical trials comparing the serotonin (5HT)-2 receptor antagonists trazodone and nefazodone with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(7):444-7.
2007: Candrian Michele; Farabaugh Amy; Pizzagalli Diego A; Baer Lee; Fava Maurizio
Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study.
The Journal of nervous and mental disease 2007;195(9):729-37.
2007: Morris David W; Rush A John; Jain Shailesh; Fava Maurizio; Wisniewski Stephen R; Balasubramani G K; Khan Ahsan Y; Trivedi Madhukar H
Diurnal mood variation in outpatients with major depressive disorder: implications for DSM-V from an analysis of the Sequenced Treatment Alternatives to Relieve Depression Study data.
The Journal of clinical psychiatry 2007;68(9):1339-47.
2007: Fraguas Renerio; Iosifescu Dan V; Alpert Jonathan; Wisniewski Stephen R; Barkin Jennifer L; Trivedi Madhukar H; Rush A John; Fava Maurizio
Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study.
Psychosomatics 2007;48(5):418-25.
2007: Perlis Roy H; Purcell Shaun; Fagerness Jesen; Cusin Cristina; Yamaki Lesley; Fava Maurizio; Smoller Jordan W
Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.
Biological psychiatry 2007;62(5):536-40.
2007: Warden Diane; Trivedi Madhukar H; Wisniewski Stephen R; Davis Lori; Nierenberg Andrew A; Gaynes Bradley N; Zisook Sidney; Hollon Steven D; Balasubramani G K; Howland Robert; Fava Maurizio; Stewart Jonathan W; Rush A John
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
The American journal of psychiatry 2007;164(8):1189-97.
2007: Husain Mustafa M; Rush A John; Trivedi Madhukar H; McClintock Shawn M; Wisniewski Stephen R; Davis Lori; Luther James F; Zisook Sid; Fava Maurizio
Pain in depression: STAR*D study findings.
Journal of psychosomatic research 2007;63(2):113-22.
2007: Fava Maurizio; Martinez James M; Greist John; Marangell Lauren B; Brown Eileen; Chen Lei; Wohlreich Madelaine M
The efficacy and tolerability of duloxetine in the treatment of anxious versus non-anxious depression: a post-hoc analysis of an open-label outpatient study.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):187-95.
2007: Fava Maurizio; Thase Michael E; DeBattista Charles; Doghramji Karl; Arora Sanjay; Hughes Rod J
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(3):153-9.
2007: Petersen Timothy; Fava Maurizio; Alpert Jonathan E; Vorono Sienna; Sanders Kathy M; Mischoulon David
Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduates.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2007;31(4):281-9.
2007: Papakostas George I; Shelton Richard C; Smith Juliana; Fava Maurizio
Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
The Journal of clinical psychiatry 2007;68(6):826-31.
2007: Perlis Roy H; Purcell Shaun; Fava Maurizio; Fagerness Jesen; Rush A John; Trivedi Madhukar H; Smoller Jordan W
Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Archives of general psychiatry 2007;64(6):689-97.
2007: Wisniewski Stephen R; Fava Maurizio; Trivedi Madhukar H; Thase Michael E; Warden Diane; Niederehe George; Friedman Edward S; Biggs Melanie M; Sackeim Harold A; Shores-Wilson Kathy; McGrath Patrick J; Lavori Philip W; Miyahara Sachiko; Rush A John
Acceptability of second-step treatments to depressed outpatients: a STAR*D report.
The American journal of psychiatry 2007;164(5):753-60.
2007: Thase Michael E; Friedman Edward S; Biggs Melanie M; Wisniewski Stephen R; Trivedi Madhukar H; Luther James F; Fava Maurizio; Nierenberg Andrew A; McGrath Patrick J; Warden Diane; Niederehe George; Hollon Steven D; Rush A John
Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report.
The American journal of psychiatry 2007;164(5):739-52.
2007: Fraguas Renerio; Marci Carl; Fava Maurizio; Iosifescu Dan V; Bankier Bettina; Loh Rebecca; Dougherty Darin D
Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment.
Psychiatry research 2007;151(1-2):169-72.
2007: Wisniewski Stephen R; Rush A John; Bryan Charlene; Shelton Richard; Trivedi Madhukar H; Marcus Sheila; Husain Mustafa M; Hollon Steven D; Fava Maurizio;
Comparison of quality of life measures in a depressed population.
The Journal of nervous and mental disease 2007;195(3):219-25.
2007: Nierenberg Andrew A; Katz Judith; Fava Maurizio
A critical overview of the pharmacologic management of treatment-resistant depression.
The Psychiatric clinics of North America 2007;30(1):13-29.
2007: Papakostas George I; Hallett Lindsay A; Smith Juliana; Tossani Eliana; Mascarini Alessandra; Burns Alana M; Birnbaum Robert J; Fava Maurizio; Alpert Jonathan E
A survey of five antidepressant properties influencing clinician's treatment choices in MDD.
Neuropsychiatric disease and treatment 2007;3(1):169-72.
2007: Krystal Andrew; Fava Maurizio; Rubens Robert; Wessel Thomas; Caron Judy; Wilson Phebe; Roth Thomas; McCall W Vaughn
Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2007;3(1):48-55.
2007: Iosifescu Dan V; Renshaw Perry F; Dougherty Darin D; Lyoo In Kyoon; Lee Ho Kyu; Fraguas Renerio; Cassano Paolo; Nierenberg Andrew A; Fava Maurizio
Major depressive disorder with anger attacks and subcortical MRI white matter hyperintensities.
The Journal of nervous and mental disease 2007;195(2):175-8.
2007: Papakostas George I; Petersen Timothy; Homberger Caitlin H; Green Cassandra H; Smith Juliana; Alpert Jonathan E; Fava Maurizio
Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2007;19(1):5-8.
2007: Cusin Cristina; Fava Maurizio; Amsterdam Jay D; Quitkin Frederic M; Reimherr Frederick W; Beasley Charles M; Rosenbaum Jerrold F; Perlis Roy H
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.
The Journal of clinical psychiatry 2007;68(1):52-7.
2007: Papakostas George I; Petersen Timothy; Sklarsky Katherine G; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.
Psychiatry research 2007;149(1-3):195-200.
2007: Papakostas George I; Fava Maurizio
A meta-analysis of clinical trials comparing milnacipran, a serotonin--norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(1):32-6.
2007: Papakostas George I; Crawford Christine M; Scalia Margaret J; Fava Maurizio
Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder. A replication of findings with the use of a double-blind, placebo-controlled trial of Hypericum perforatum versus fluoxetine.
Neuropsychobiology 2007;56(2-3):132-7.
2007: Mallinckrodt Craig H; Prakash Apurva; Houston John P; Swindle Ralph; Detke Michael J; Fava Maurizio
Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
Neuropsychobiology 2007;56(2-3):73-85.
2007: Fava Maurizio
Augmenting antidepressants with folate: a clinical perspective.
The Journal of clinical psychiatry 2007;68 Suppl 10():4-7.
2007: Papakostas George I; Perlis Roy H; Seifert Cheryl; Fava Maurizio
Antidepressant dose reduction and the risk of relapse in major depressive disorder.
Psychotherapy and psychosomatics 2007;76(5):266-70.
2007: Fraguas Renerio; Iosifescu Dan V; Bankier Bettina; Perlis Roy; Clementi-Craven Nicoletta; Alpert Jonathan; Fava Maurizio
Major depressive disorder with anger attacks and cardiovascular risk factors.
International journal of psychiatry in medicine 2007;37(1):99-111.
2007: Perlis Roy H; Beasley Charles M; Wines James D; Tamura Roy N; Cusin Cristina; Shear Deborah; Amsterdam Jay; Quitkin Frederick; Strong Robert E; Rosenbaum Jerrold F; Fava Maurizio
Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.
Psychotherapy and psychosomatics 2007;76(1):40-6.
2007: Farabaugh Amy; Mischoulon David; Schwartz Faye; Pender Maribeth; Fava Maurizio; Alpert Jonathan
Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
Depression and anxiety 2007;24(6):433-9.
2006: Papakostas George I; Nutt David J; Hallett Lindsay A; Tucker Vivian L; Krishen Alok; Fava Maurizio
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
Biological psychiatry 2006;60(12):1350-5.
2006: Fava Maurizio; Graves Lesley M; Benazzi Franco; Scalia Margaret J; Iosifescu Dan V; Alpert Jonathan E; Papakostas George I
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.
The Journal of clinical psychiatry 2006;67(11):1754-9.
2006: Fava Maurizio; Rush A John; Alpert Jonathan E; Carmin Cheryl N; Balasubramani G K; Wisniewski Stephen R; Trivedi Madhukar H; Biggs Melanie M; Shores-Wilson Kathy
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(13):823-35.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Stewart Jonathan W; Warden Diane; Niederehe George; Thase Michael E; Lavori Philip W; Lebowitz Barry D; McGrath Patrick J; Rosenbaum Jerrold F; Sackeim Harold A; Kupfer David J; Luther James; Fava Maurizio
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: Papakostas George I; Fava Maurizio
A metaanalysis of clinical trials comparing moclobemide with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2006;51(12):783-90.
2006: Trivedi Madhukar H; Fava Maurizio; Marangell Lauren B; Osser David N; Shelton Richard C
Use of treatment algorithms for depression.
The Journal of clinical psychiatry 2006;67(9):1458-65.
2006: Yeung Albert; Yu Shu-Ching; Fung Freddy; Vorono Sienna; Fava Maurizio
Recognizing and engaging depressed Chinese Americans in treatment in a primary care setting.
International journal of geriatric psychiatry 2006;21(9):819-23.
2006: McGrath Patrick J; Stewart Jonathan W; Quitkin Frederic M; Chen Ying; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio; Cheng Jianfeng; Petkova Eva
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: McGrath Patrick J; Stewart Jonathan W; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Thase Michael E; Davis Lori; Biggs Melanie M; Shores-Wilson Kathy; Luther James F; Niederehe George; Warden Diane; Rush A John
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Nierenberg Andrew A; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Thase Michael E; McGrath Patrick J; Alpert Jonathan E; Warden Diane; Luther James F; Niederehe George; Lebowitz Barry; Shores-Wilson Kathy; Rush A John
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1519-30; quiz 1665.
2006: Rush A John; Kraemer Helena C; Sackeim Harold A; Fava Maurizio; Trivedi Madhukar H; Frank Ellen; Ninan Philip T; Thase Michael E; Gelenberg Alan J; Kupfer David J; Regier Darrel A; Rosenbaum Jerrold F; Ray Oakley; Schatzberg Alan F;
Report by the ACNP Task Force on response and remission in major depressive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1841-53.
2006: Simon Naomi M; Smoller Jordan W; McNamara Kate L; Maser Richard S; Zalta Alyson K; Pollack Mark H; Nierenberg Andrew A; Fava Maurizio; Wong Kwok-Kin
Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging.
Biological psychiatry 2006;60(5):432-5.
2006: Fraguas Renerio; Papakostas George I; Mischoulon David; Bottiglieri Teodoro; Alpert Jonathan; Fava Maurizio
Anger attacks in major depressive disorder and serum levels of homocysteine.
Biological psychiatry 2006;60(3):270-4.
2006: Denninger John W; Papakostas George I; Mahal Yasmin; Merens Wendelien; Alpert Jonathan E; Nierenberg Andrew A; Yeung Albert; Fava Maurizio
Somatic symptoms in outpatients with major depressive disorder treated with fluoxetine.
Psychosomatics 2006;47(4):348-52.
2006: Fava Maurizio; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Alpert Jonathan E; McGrath Patrick J; Thase Michael E; Warden Diane; Biggs Melanie; Luther James F; Niederehe George; Ritz Louise; Trivedi Madhukar H
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.
The American journal of psychiatry 2006;163(7):1161-72.
2006: Papakostas George I; Miller Karen K; Petersen Timothy; Sklarsky Katherine G; Hilliker Sarah E; Klibanski Anne; Fava Maurizio
Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine.
The Journal of clinical psychiatry 2006;67(6):952-7.
2006: Farabaugh Amy H; Sonawalla Shamsah B; Fava Maurizio; Pedrelli Paola; Papakostas George I; Schwartz Faye; Mischoulon David
Differences in cognitive factors between "true drug" versus "placebo pattern" response to fluoxetine as defined by pattern analysis.
Human psychopharmacology 2006;21(4):221-5.
2006: Kessler Ronald C; Coccaro Emil F; Fava Maurizio; Jaeger Savina; Jin Robert; Walters Ellen
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication.
Archives of general psychiatry 2006;63(6):669-78.
2006: Fava Maurizio; Detke Michael J; Balestrieri Matteo; Wang Fujun; Raskin Joel; Perahia David
Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
Journal of psychiatric research 2006;40(4):328-36.
2006: Fava Maurizio; McCall W Vaughn; Krystal Andrew; Wessel Thomas; Rubens Robert; Caron Judy; Amato David; Roth Thomas
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Biological psychiatry 2006;59(11):1052-60.
2006: Papakostas George I; Petersen Timothy J; Burns Alana M; Fava Maurizio
Adjunctive atomoxetine for residual fatigue in major depressive disorder.
Journal of psychiatric research 2006;40(4):370-3.
2006: Fava Maurizio
Pharmacological approaches to the treatment of residual symptoms.
Journal of psychopharmacology (Oxford, England) 2006;20(3 Suppl):29-34.
2006: Khan Ahsan Y; Carrithers Joe; Preskorn Sheldon H; Lear Rex; Wisniewski Stephen R; John Rush A; Stegman Diane; Kelley Colleen; Kreiner Karen; Nierenberg Andrew A; Fava Maurizio
Clinical and demographic factors associated with DSM-IV melancholic depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2006;18(2):91-8.
2006: Papakostas George I; Petersen Timothy J; Perlis Roy H; Judy Amy E; Burns Alana M; Alpert Jonathan E; Birnbaum Robert J; Fava Maurizio
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorder.
Journal of clinical psychopharmacology 2006;26(2):216-8.
2006: Trivedi Madhukar H; Fava Maurizio; Wisniewski Stephen R; Thase Michael E; Quitkin Frederick; Warden Diane; Ritz Louise; Nierenberg Andrew A; Lebowitz Barry D; Biggs Melanie M; Luther James F; Shores-Wilson Kathy; Rush A John;
Medication augmentation after the failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1243-52.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Stewart Jonathan W; Nierenberg Andrew A; Thase Michael E; Ritz Louise; Biggs Melanie M; Warden Diane; Luther James F; Shores-Wilson Kathy; Niederehe George; Fava Maurizio;
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: Rush A John; Bernstein Ira H; Trivedi Madhukar H; Carmody Thomas J; Wisniewski Stephen; Mundt James C; Shores-Wilson Kathy; Biggs Melanie M; Woo Ada; Nierenberg Andrew A; Fava Maurizio
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.
Biological psychiatry 2006;59(6):493-501.
2006: Thase Michael E; Fava Maurizio; DeBattista Charles; Arora Sanjay; Hughes Rod J
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
CNS spectrums 2006;11(2):93-102.
2006: Iosifescu Dan V; Renshaw Perry F; Lyoo In Kyoon; Lee Ho Kyu; Perlis Roy H; Papakostas George I; Nierenberg Andrew A; Fava Maurizio
Brain white-matter hyperintensities and treatment outcome in major depressive disorder.
The British journal of psychiatry : the journal of mental science 2006;188():180-5.
2006: Papakostas George I; Perlis Roy H; Scalia Margaret J; Petersen Timothy J; Fava Maurizio
A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder.
Journal of clinical psychopharmacology 2006;26(1):56-60.
2006: Trivedi Madhukar H; Rush A John; Wisniewski Stephen R; Nierenberg Andrew A; Warden Diane; Ritz Louise; Norquist Grayson; Howland Robert H; Lebowitz Barry; McGrath Patrick J; Shores-Wilson Kathy; Biggs Melanie M; Balasubramani G K; Fava Maurizio;
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
The American journal of psychiatry 2006;163(1):28-40.
2006: Petersen Timothy; Iosifescu Dan V; Papakostas George I; Shear Deborah L; Fava Maurizio
Clinical characteristics of depressed patients with comorbid diabetes mellitus.
International clinical psychopharmacology 2006;21(1):43-7.
2006: Trivedi Madhukar H; Fava Maurizio; Marangell Lauren B; Osser David N; Shelton Richard C
Use of treatment algorithms for depression.
Primary care companion to the Journal of clinical psychiatry 2006;8(5):291-8.
2006: Harley Rebecca; Petersen Timothy; Scalia Margaret; Papakostas George I; Farabaugh Amy; Fava Maurizio
Problem-solving ability and comorbid personality disorders in depressed outpatients.
Depression and anxiety 2006;23(8):496-501.
2006: Fava Maurizio
Prospective studies of adverse events related to antidepressant discontinuation.
The Journal of clinical psychiatry 2006;67 Suppl 4():14-21.
2006: Fava Maurizio; Rush A John
Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.
Psychotherapy and psychosomatics 2006;75(3):139-53.
2006: Papakostas George I; Worthington John J; Iosifescu Dan V; Kinrys Gustavo; Burns Alana M; Fisher Lauren B; Homberger Caitlin H; Mischoulon David; Fava Maurizio
The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
Depression and anxiety 2006;23(3):178-81.
2006: Dougherty Darin D; Bonab Ali A; Ottowitz William E; Livni Eli; Alpert Nathaniel M; Rauch Scott L; Fava Maurizio; Fischman Alan J
Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks.
Depression and anxiety 2006;23(3):175-7.
2005: Iosifescu Dan V; Papakostas George I; Lyoo In Kyoon; Lee Ho Kyu; Renshaw Perry F; Alpert Jonathan E; Nierenberg Andrew; Fava Maurizio
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).
Psychiatry research 2005;140(3):291-9.
2005: Papakostas George I; Iosifescu Dan V; Renshaw Perry F; Lyoo In Kyoon; Lee Ho Kyu; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part II).
Psychiatry research 2005;140(3):301-7.
2005: Wohlreich Madelaine M; Martinez James M; Mallinckrodt Craig H; Prakash Apurva; Watkin John G; Fava Maurizio
An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
Journal of clinical psychopharmacology 2005;25(6):552-60.
2005: Papakostas George I; Petersen Timothy; Lebowitz Barry D; Mischoulon David; Ryan Julie L; Nierenberg Andrew A; Bottiglieri Teodoro; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(4):523-8.
2005: Farabaugh Amy; Ongur Dost; Fava Maurizio; Hamill Sarah K; Burns Alana M; Alpert Jonathan
Personality disorders and the trimensional personality questionnaire factors in major depressive disorder.
The Journal of nervous and mental disease 2005;193(11):747-50.
2005: Wohlreich Madelaine M; Mallinckrodt Craig H; Watkin John G; Wilson Michael G; Greist John H; Delgado Pedro L; Fava Maurizio
Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2005;17(4):259-68.
2005: Papakostas George I; Petersen Timothy J; Kinrys Gustavo; Burns Alana M; Worthington John J; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(10):1326-30.
2005: Fava Maurizio; Alpert Jonathan; Nierenberg Andrew A; Mischoulon David; Otto Michael W; Zajecka John; Murck Harald; Rosenbaum Jerrold F
A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Journal of clinical psychopharmacology 2005;25(5):441-7.
2005: Iosifescu Dan V; Clementi-Craven Nicoletta; Fraguas Renerio; Papakostas George I; Petersen Timothy; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Cardiovascular risk factors may moderate pharmacological treatment effects in major depressive disorder.
Psychosomatic medicine 2005;67(5):703-6.
2005: Iosifescu Dan V; Nierenberg Andrew A; Mischoulon David; Perlis Roy H; Papakostas George I; Ryan Julie L; Alpert Jonathan E; Fava Maurizio
An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2005;66(8):1038-42.
2005: Petersen Timothy; Papakostas George I; Posternak Michael A; Kant Alexis; Guyker Wendy M; Iosifescu Dan V; Yeung Albert S; Nierenberg Andrew A; Fava Maurizio
Empirical testing of two models for staging antidepressant treatment resistance.
Journal of clinical psychopharmacology 2005;25(4):336-41.
2005: Papakostas George I; Petersen Timothy J; Green Cassandra; Iosifescu Dan V; Yeung Albert S; Nierenberg Andrew A; Fava Maurizio; Posternak Michael A
A description of next-step switching versus augmentation practices for outpatients with treatment-resistant major depressive disorder enrolled in an academic specialty clinic.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2005;17(3):161-5.
2005: Farabaugh Amy; Fava Maurizio; Mischoulon David; Sklarsky Katie; Petersen Timothy; Alpert Jonathan
Relationships between major depressive disorder and comorbid anxiety and personality disorders.
Comprehensive psychiatry 2005;46(4):266-71.
2005: Rush A John; Zimmerman Mark; Wisniewski Stephen R; Fava Maurizio; Hollon Steven D; Warden Diane; Biggs Melanie M; Shores-Wilson Kathy; Shelton Richard C; Luther James F; Thomas Brandi; Trivedi Madhukar H
Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.
Journal of affective disorders 2005;87(1):43-55.
2005: Cassano Paolo; Lattanzi Lorenzo; Fava Maurizio; Navari Serena; Battistini Giulia; Abelli Marianna; Cassano Giovanni B
Ropinirole in treatment-resistant depression: a 16-week pilot study.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2005;50(6):357-60.
2005: Tossani Eliana; Cassano Paolo; Fava Maurizio
Depression and renal disease.
Seminars in dialysis 2005;18(2):73-81.
2005: Farabaugh Amy; Mischoulon David; Fava Maurizio; Wu Shirley L; Mascarini Alessandra; Tossani Eliana; Alpert Jonathan E
The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.
International clinical psychopharmacology 2005;20(2):87-91.
2005: Papakostas George I; Petersen Timothy; Iosifescu Dan V; Burns Alana M; Nierenberg Andrew A; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
Obesity among outpatients with major depressive disorder.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):59-63.
2005: Perlis Roy H; Fraguas Renerio; Fava Maurizio; Trivedi Madhukar H; Luther James F; Wisniewski Stephen R; Rush A John
Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
The Journal of clinical psychiatry 2005;66(2):159-66; quiz 147, 273-4.
2005: Fava Maurizio; Thase Michael E; DeBattista Charles
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
The Journal of clinical psychiatry 2005;66(1):85-93.
2005: Yeung Albert; Kung Winnie W; Murakami Jessica L; Mischoulon David; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Outcomes of recognizing depressed Chinese American patients in primary care.
International journal of psychiatry in medicine 2005;35(3):213-24.
2005: Cassano Paolo; Soares Claudio N; Cusin Cristina; Mascarini Alessandra; Cohen Lee S; Fava Maurizio
Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetine.
Psychotherapy and psychosomatics 2005;74(6):362-5.
2005: Yang Huaiyu; Cusin Cristina; Fava Maurizio
Is there a placebo problem in antidepressant trials?
Current topics in medicinal chemistry 2005;5(11):1077-86.
2005: Fava Maurizio; Rush A John; Thase Michael E; Clayton Anita; Stahl Stephen M; Pradko James F; Johnston J Andrew
15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
Primary care companion to the Journal of clinical psychiatry 2005;7(3):106-13.
2005: Ongur Dost; Farabaugh Amy; Iosifescu Dan V; Perlis Roy; Fava Maurizio
Tridimensional personality questionnaire factors in major depressive disorder: relationship to anxiety disorder comorbidity and age of onset.
Psychotherapy and psychosomatics 2005;74(3):173-8.
2004: Alpert Jonathan E; Papakostas George; Mischoulon David; Worthington John J; Petersen Timothy; Mahal Yasmin; Burns Alana; Bottiglieri Teodoro; Nierenberg Andrew A; Fava Maurizio
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine.
Journal of clinical psychopharmacology 2004;24(6):661-4.
2004: Farabaugh A H; Mischoulon D; Fava M; Green C; Guyker W; Alpert J
The potential relationship between levels of perceived stress and subtypes of major depressive disorder (MDD).
Acta psychiatrica Scandinavica 2004;110(6):465-70.
2004: Nierenberg Andrew A; Trivedi Madhukar H; Ritz Louise; Burroughs Diane; Greist John; Sackeim Harold; Kornstein Susan; Schwartz Terry; Stegman Diane; Fava Maurizio; Wisniewski Stephen R
Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines.
Journal of psychiatric research 2004;38(6):583-9.
2004: Farabaugh Amy; Mischoulon David; Fava Maurizio; Guyker Wendy; Alpert Jonathan
The overlap between personality disorders and major depressive disorder (MDD).
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2004;16(4):217-24.
2004: Fava Maurizio; Alpert Jonathan E; Carmin Cheryl N; Wisniewski Stephen R; Trivedi Madhukar H; Biggs Melanie M; Shores-Wilson Kathy; Morgan Don; Schwartz Terry; Balasubramani G K; Rush A John
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
Psychological medicine 2004;34(7):1299-308.
2004: Papakostas George I; Petersen Timothy; Denninger John W; Tossani Eliana; Pava Joel A; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
Journal of clinical psychopharmacology 2004;24(5):507-11.
2004: Iosifescu Dan V; Nierenberg Andrew A; Alpert Jonathan E; Papakostas George I; Perlis Roy H; Sonawalla Shamsah; Fava Maurizio
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment.
Psychosomatics 2004;45(5):419-25.
2004: Papakostas George I; Petersen Timothy; Mischoulon David; Green Cassandra H; Nierenberg Andrew A; Bottiglieri Teodoro; Rosenbaum Jerrold F; Alpert Jonathan E; Fava Maurizio
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.
The Journal of clinical psychiatry 2004;65(8):1096-8.
2004: Papakostas George I; Petersen Timothy; Mischoulon David; Ryan Julie L; Nierenberg Andrew A; Bottiglieri Teodoro; Rosenbaum Jerrold F; Alpert Jonathan E; Fava Maurizio
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.
The Journal of clinical psychiatry 2004;65(8):1090-5.
2004: Alpert Jonathan E; Franznick Dana A; Hollander Steven B; Fava Maurizio
Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
The Journal of clinical psychiatry 2004;65(8):1069-75.
2004: Dougherty Darin D; Rauch Scott L; Deckersbach Thilo; Marci Carl; Loh Rebecca; Shin Lisa M; Alpert Nathaniel M; Fischman Alan J; Fava Maurizio
Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks.
Archives of general psychiatry 2004;61(8):795-804.
2004: Yeung Albert; Kung Winnie W; Chung Henry; Rubenstein Grace; Roffi Pamela; Mischoulon David; Fava Maurizio
Integrating psychiatry and primary care improves acceptability to mental health services among Chinese Americans.
General hospital psychiatry 2004;26(4):256-60.
2004: Petersen Timothy; Papakostas George I; Mahal Yasmin; Guyker Wendy M; Beaumont Erin C; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Psychosocial functioning in patients with treatment resistant depression.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(4):196-201.
2004: Iosifescu Dan V; Bankier Bettina; Fava Maurizio
Impact of medical comorbid disease on antidepressant treatment of major depressive disorder.
Current psychiatry reports 2004;6(3):193-201.
2004: Papakostas George I; Petersen Timothy; Hughes Megan E; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Anxiety and somatic symptoms as predictors of treatment-related adverse events in major depressive disorder.
Psychiatry research 2004;126(3):287-90.
2004: Perlis Roy H; Iosifescu Dan V; Alpert Jonathan; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Effect of medical comorbidity on response to fluoxetine augmentation or dose increase in outpatients with treatment-resistant depression.
Psychosomatics 2004;45(3):224-9.
2004: Wisniewski Stephen R; Stegman Diane; Trivedi Madhukar; Husain Mustafa M; Eng Heather; Shores-Wilson Kathy; Luther James; Biggs Melanie M; Burroughs Diane; Ritz A Louise; Fava Maurizio; Quitkin Frederic; Rush A John;
Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
Journal of psychiatric research 2004;38(3):241-8.
2004: Petersen T; Harley R; Papakostas G I; Montoya H D; Fava M; Alpert J E
Continuation cognitive-behavioural therapy maintains attributional style improvement in depressed patients responding acutely to fluoxetine.
Psychological medicine 2004;34(3):555-61.
2004: Papakostas George I; Petersen Timothy J; Iosifescu Dan V; Summergrad Paul; Sklarsky Katherine G; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorder.
The Journal of clinical psychiatry 2004;65(4):543-6.
2004: Fava Maurizio; Mallinckrodt Craig H; Detke Michael J; Watkin John G; Wohlreich Madelaine M
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
The Journal of clinical psychiatry 2004;65(4):521-30.
2004: Yeung Albert; Chang Doris; Gresham Robert L; Nierenberg Andrew A; Fava Maurizio
Illness beliefs of depressed Chinese American patients in primary care.
The Journal of nervous and mental disease 2004;192(4):324-7.
2004: Joliat Melissa J; Schmidt Mark E; Fava Maurizio; Zhang Shuyu; Michelson David; Trapp Nancy J; Miner Cherri M
Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.
The Journal of clinical psychiatry 2004;65(3):373-8.
2004: Papakostas George I; Ongür Dost; Iosifescu Dan V; Mischoulon David; Fava Maurizio
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2004;14(2):135-42.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Papakostas George I; Petersen Timothy J; Nierenberg Andrew A; Murakami Jessica L; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio
Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
The Journal of clinical psychiatry 2004;65(2):217-21.
2004: Cassano Paolo; Fava Maurizio
Tolerability issues during long-term treatment with antidepressants.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2004;16(1):15-25.
2004: Yeung Albert; Chan Raymond; Mischoulon David; Sonawalla Shamsah; Wong Eileen; Nierenberg Andrew A; Fava Maurizio
Prevalence of major depressive disorder among Chinese-Americans in primary care.
General hospital psychiatry 2004;26(1):24-30.
2004: Papakostas George I; Petersen Timothy; Mahal Yasmin; Mischoulon David; Nierenberg Andrew A; Fava Maurizio
Quality of life assessments in major depressive disorder: a review of the literature.
General hospital psychiatry 2004;26(1):13-7.
2004: Fava Maurizio
Daytime sleepiness and insomnia as correlates of depression.
The Journal of clinical psychiatry 2004;65 Suppl 16():27-32.
2004: Mischoulon David; Opitz Gudrun; Kelly Karen; Fava Maurizio; Rosenbaum Jerrold F
A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: comparing patients who recently discontinued an SSRI with those on no recent antidepressant treatment.
Depression and anxiety 2004;19(1):43-50.
2003: Iosifescu Dan V; Nierenberg Andrew A; Alpert Jonathan E; Smith Megan; Bitran Stella; Dording Christina; Fava Maurizio
The impact of medical comorbidity on acute treatment in major depressive disorder.
The American journal of psychiatry 2003;160(12):2122-7.
2003: Perlis R H; Alpert J; Nierenberg A A; Mischoulon D; Yeung A; Rosenbaum J F; Fava M
Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
Acta psychiatrica Scandinavica 2003;108(6):432-8.
2003: Papakostas George I; Alpert Jonathan E; Fava Maurizio
S-adenosyl-methionine in depression: a comprehensive review of the literature.
Current psychiatry reports 2003;5(6):460-6.
2003: Papakostas George I; Petersen Timothy J; Farabaugh Amy H; Murakami Jessica L; Pava Joel A; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder.
The Journal of clinical psychiatry 2003;64(11):1357-61.
2003: Perlis Roy H; Mischoulon David; Smoller Jordan W; Wan Yu-Jui Yvonne; Lamon-Fava Stefania; Lin Keh-Ming; Rosenbaum Jerrold F; Fava Maurizio
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
Biological psychiatry 2003;54(9):879-83.
2003: Papakostas George I; Petersen Timothy; Denninger John W; Montoya Heidi D; Nierenberg Andrew A; Alpert Jonathan E; Fava Maurizio
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(3-4):187-92.
2003: Papakostas George I; Petersen Timothy; Worthington John J; Roffi Pamela A; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
International clinical psychopharmacology 2003;18(5):293-6.
2003: Fava Maurizio; McGrath Patrick J; Sheu Wang-Pui;
Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine.
Journal of clinical psychopharmacology 2003;23(4):365-9.
2003: Sachs Gary S; Thase Michael E; Otto Michael W; Bauer Mark; Miklowitz David; Wisniewski Stephen R; Lavori Philip; Lebowitz Barry; Rudorfer Mathew; Frank Ellen; Nierenberg Andrew A; Fava Maurizio; Bowden Charles; Ketter Terence; Marangell Lauren; Calabrese Joseph; Kupfer David; Rosenbaum Jerrold F
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD).
Biological psychiatry 2003;53(11):1028-42.
2003: Fava Maurizio; Rush A John; Trivedi Madhukar H; Nierenberg Andrew A; Thase Michael E; Sackeim Harold A; Quitkin Frederic M; Wisniewski Steven; Lavori Philip W; Rosenbaum Jerrold F; Kupfer David J
Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.
The Psychiatric clinics of North America 2003;26(2):457-94, x.
2003: Papakostas George I; Petersen Timothy; Iosifescu Dan V; Roffi Pamela A; Alpert Jonathan E; Rosenbaum Jerrold F; Fava Maurizio; Nierenberg Andrew A
Axis III disorders in treatment-resistant major depressive disorder.
Psychiatry research 2003;118(2):183-8.
2003: Papakostas George I; Petersen Timothy; Mischoulon David; Hughes Megan E; Alpert Jonathan E; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Serum cholesterol and serotonergic function in major depressive disorder.
Psychiatry research 2003;118(2):137-45.
2003: Papakostas George I; Petersen Timothy; Denninger John; Sonawalla Shamsah B; Mahal Yasmin; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio
Somatic symptoms in treatment-resistant depression.
Psychiatry research 2003;118(1):39-45.
2003: Fava Maurizio; Evins A Eden; Dorer David J; Schoenfeld David A
The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.
Psychotherapy and psychosomatics 2003;72(3):115-27.
2003: Fava Maurizio
Diagnosis and definition of treatment-resistant depression.
Biological psychiatry 2003;53(8):649-59.
2003: Fava Maurizio; Papakostas George I; Petersen Timothy; Mahal Yasmin; Quitkin Frederick; Stewart Jonathan; McGrath Patrick
Switching to bupropion in fluoxetine-resistant major depressive disorder.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(1):17-22.
2003: Alpert Jonathan E; Petersen Timothy; Roffi Pamela A; Papakostas George I; Freed Rachel; Smith Megan M; Spector Andrew R; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacks.
Psychotherapy and psychosomatics 2003;72(2):102-6.
2003: Nierenberg Andrew A; Papakostas George I; Petersen Timothy; Montoya Heidi D; Worthington John J; Tedlow Joyce; Alpert Jonathan E; Fava Maurizio
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.
Journal of clinical psychopharmacology 2003;23(1):92-5.
2003: Nierenberg Andrew A; Papakostas George I; Petersen Timothy; Kelly Karen E; Iacoviello Brian M; Worthington John J; Tedlow Joyce; Alpert Jonathan E; Fava Maurizio
Nortriptyline for treatment-resistant depression.
The Journal of clinical psychiatry 2003;64(1):35-9.
2003: Papakostas George I; Petersen Timothy; Mischoulon David; Hughes Megan E; Spector Andrew R; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.
Comprehensive psychiatry 2003;44(1):44-50.
2003: Fava Maurizio
Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.
The Journal of clinical psychiatry 2003;64 Suppl 14():30-4.
2003: Fava Maurizio
The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
The Journal of clinical psychiatry 2003;64 Suppl 13():26-9.
2003: Petersen Timothy J; Alpert Jonathan E; Papakostas George I; Bernstein Emily M; Freed Rachel; Smith Megan M; Fava Maurizio
Early-onset depression and the emotional and behavioral characteristics of offspring.
Depression and anxiety 2003;18(2):104-8.
2003: Papakostas George I; Petersen Timothy; Sonawalla Shamsah B; Merens Wendelien; Iosifescu Dan V; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
Serum cholesterol in treatment-resistant depression.
Neuropsychobiology 2003;47(3):146-51.
2003: Fava Maurizio
Depression with physical symptoms: treating to remission.
The Journal of clinical psychiatry 2003;64 Suppl 7():24-8.
2002: Matthews John D; Bottonari Kathryn A; Polania Laura M; Mischoulon David; Dording Christina M; Irvin Robert; Fava Maurizio
An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analyses.
The Journal of clinical psychiatry 2002;63(12):1164-70.
2002: Sonawalla Shamsah B; Farabaugh Amy H; Leslie Vinita M; Pava Joel A; Matthews John D; Fava Maurizio
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(7-8):1415-9.
2002: Mischoulon David; Dougherty Darin D; Bottonari Kathryn A; Gresham Robert L; Sonawalla Shamsah B; Fischman Alan J; Fava Maurizio
An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding.
Psychiatry research 2002;116(3):151-61.
2002: Mischoulon David; Fava Maurizio
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence.
The American journal of clinical nutrition 2002;76(5):1158S-61S.
2002: Cassano Paolo; Fava Maurizio
Depression and public health: an overview.
Journal of psychosomatic research 2002;53(4):849-57.
2002: Perlis Roy H; Nierenberg Andrew A; Alpert Jonathan E; Pava Joel; Matthews John D; Buchin Jaqueline; Sickinger Andrea H; Fava Maurizio
Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
Journal of clinical psychopharmacology 2002;22(5):474-80.
2002: Dording Christina M; Mischoulon David; Petersen Timothy J; Kornbluh Rebecca; Gordon Johanna; Nierenberg Andrew A; Rosenbaum Jerrold E; Fava Maurizio
The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(3):143-7.
2002: Sonawalla Shamsah B; Farabaugh Amy; Johnson Mary W; Morray Meridith; Delgado Margarita L; Pingol Mark G; Rosenbaum Jerrold F; Fava Maurizio
Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Journal of psychopharmacology (Oxford, England) 2002;16(3):215-9.
2002: Tedlow Joyce; Smith Megan; Neault Nicole; Polania Laura; Alpert Jonathan; Nierenberg Andrew; Fava Maurizio
Melancholia and axis II comorbidity.
Comprehensive psychiatry 2002;43(5):331-5.
2002: Petersen Timothy; Hughes Megan; Papakostas George I; Kant Alexis; Fava Maurizio; Rosenbaum Jerrold F; Nierenberg Andrew A
Treatment-resistant depression and Axis II comorbidity.
Psychotherapy and psychosomatics 2002;71(5):269-74.
2002: Fava M; Farabaugh A H; Sickinger A H; Wright E; Alpert J E; Sonawalla S; Nierenberg A A; Worthington J J
Personality disorders and depression.
Psychological medicine 2002;32(6):1049-57.
2002: Fava Maurizio; Alpert Jonathan; Nierenberg Andrew; Lagomasino Isabel; Sonawalla Shamsah; Tedlow Joyce; Worthington John; Baer Lee; Rosenbaum Jerrold F
Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Journal of clinical psychopharmacology 2002;22(4):379-87.
2002: Sonawalla Shamsah B; Papakostas George I; Petersen Timothy J; Yeung Albert S; Smith Megan M; Sickinger Andrea H; Gordon Johanna; Israel Joshua A; Tedlow Joyce R; Lamon-Fava Stefania; Fava Maurizio
Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
Psychosomatics 2002;43(4):310-6.
2002: Fava Maurizio; Schmidt Mark E; Zhang Shuyu; Gonzales Jill; Raute Nancy J; Judge Rajinder
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment.
Psychotherapy and psychosomatics 2002;71(4):195-9.
2002: Schmidt Mark E; Fava Maurizio; Zhang Shuyu; Gonzales Jill; Raute Nancy J; Judge Rajinder
Treatment approaches to major depressive disorder relapse. Part 1: dose increase.
Psychotherapy and psychosomatics 2002;71(4):190-4.
2002: Nierenberg Andrew A; Phillips Katharine A; Petersen Timothy J; Kelly Karen E; Alpert Jonathan E; Worthington John J; Tedlow Joyce R; Rosenbaum Jerrold F; Fava Maurizio
Body dysmorphic disorder in outpatients with major depression.
Journal of affective disorders 2002;69(1-3):141-8.
2002: Fava Maurizio
Somatic symptoms, depression, and antidepressant treatment.
The Journal of clinical psychiatry 2002;63(4):305-7.
2002: Sonawalla Shamsah B; Farabaugh Amy H; Leslie Vinita M; Pava Joel A; Matthews John D; Fava Maurizio
Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(3):415-9.
2002: Farabaugh Amy; Mischoulon David; Yeung Albert; Alpert Jonathan; Matthews John; Pava Joel; Fava Maurizio
Predictors of stable personality disorder diagnoses in outpatients with remitted depression.
The Journal of nervous and mental disease 2002;190(4):248-56.
2002: Yeung A; Neault N; Sonawalla S; Howarth S; Fava M; Nierenberg A A
Screening for major depression in Asian-Americans: a comparison of the Beck and the Chinese Depression Inventory.
Acta psychiatrica Scandinavica 2002;105(4):252-7.
2002: Fava Maurizio; Hoog Sharon L; Judge Rajinder A; Kopp Joan B; Nilsson Mary E; Gonzales Jill S
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Journal of clinical psychopharmacology 2002;22(2):137-47.
2002: Alpert Jonathan E; Mischoulon David; Rubenstein Grace E F; Bottonari Kathryn; Nierenberg Andrew A; Fava Maurizio
Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2002;14(1):33-8.
2002: Perlis Roy H; Fava Maurizio; Nierenberg Andrew A; Pollack Mark H; Falk William E; Kienke Allison S; Rosenbaum Jerrold F
Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice.
Harvard review of psychiatry 2002;10(2):109-14.
2002: Yeung Albert; Howarth Shauna; Chan Raymond; Sonawalla Shamsah; Nierenberg Andrew A; Fava Maurizio
Use of the Chinese version of the Beck Depression Inventory for screening depression in primary care.
The Journal of nervous and mental disease 2002;190(2):94-9.
2002: Petersen Timothy; Dording Christina; Neault Nicole B; Kornbluh Rebecca; Alpert Jonathan E; Nierenberg Andrew A; Rosenbaum Jerrold F; Fava Maurizio
A survey of prescribing practices in the treatment of depression.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):177-87.
2002: Petersen Timothy; Papakostas George I; Bottonari Kathryn; Iacoviello Brian; Alpert Jonathan E; Fava Maurizio; Nierenberg Andrew A
NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.
Psychiatry research 2002;109(1):9-16.
2002: Fava Maurizio; Rankin Meridith
Sexual functioning and SSRIs.
The Journal of clinical psychiatry 2002;63 Suppl 5():13-6; discussion 23-5.
2001: Petersen T; Bottonari K; Alpert J E; Fava M; Nierenberg A A
Use of the five-factory inventory in characterizing patients with major depressive disorder.
Comprehensive psychiatry 2001;42(6):488-93.
2001: Blais M A; Otto M W; Zucker B G; McNally R J; Schmidt N B; Fava M; Pollack M H
The anxiety sensitivity index: item analysis and suggestions for refinement.
Journal of personality assessment 2001;77(2):272-94.
2001: Petersen T; Gordon J A; Kant A; Fava M; Rosenbaum J F; Nierenberg A A
Treatment resistant depression and axis I co-morbidity.
Psychological medicine 2001;31(7):1223-9.
2001: Fava M; Dunner D L; Greist J H; Preskorn S H; Trivedi M H; Zajecka J; Cohen M
Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
The Journal of clinical psychiatry 2001;62(6):413-20.
2001: Spillmann M K; Van der Does A J; Rankin M A; Vuolo R D; Alpert J E; Nierenberg A A; Rosenbaum J F; Hayden D; Schoenfeld D; Fava M
Tryptophan depletion in SSRI-recovered depressed outpatients.
Psychopharmacology 2001;155(2):123-7.
2001: Mischoulon D; McColl-Vuolo R; Howarth S; Lagomasino I T; Alpert J E; Nierenberg A A; Fava M
Management of major depression in the primary care setting.
Psychotherapy and psychosomatics 2001;70(2):103-7.
2001: Kornbluh R; Papakostas G I; Petersen T; Neault N B; Nierenberg A A; Rosenbaum J F; Fava M
A survey of prescribing preferences in the treatment of refractory depression: recent trends.
Psychopharmacology bulletin 2001;35(3):150-6.
2001: Iosifescu D V; Howarth S; Alpert J E; Nierenberg A A; Worthington J J; Fava M
T3 blood levels and treatment outcome in depression.
International journal of psychiatry in medicine 2001;31(4):367-73.
2001: Fava M
Augmentation and combination strategies in treatment-resistant depression.
The Journal of clinical psychiatry 2001;62 Suppl 18():4-11.
2000: Mischoulon D; Fava M
Docosahexanoic acid and omega-3 fatty acids in depression.
The Psychiatric clinics of North America 2000;23(4):785-94.
2000: Fava M; Judge R; Hoog S L; Nilsson M E; Koke S C
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
The Journal of clinical psychiatry 2000;61(11):863-7.
2000: Schmidt M E; Fava M; Robinson J M; Judge R
The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
The Journal of clinical psychiatry 2000;61(11):851-7.
2000: Mischoulon D; Burger J K; Spillmann M K; Worthington J J; Fava M; Alpert J E
Anemia and macrocytosis in the prediction of serum folate and vitamin B12 status, and treatment outcome in major depression.
Journal of psychosomatic research 2000;49(3):183-7.
2000: Sporn J; Ghaemi S N; Sambur M R; Rankin M A; Recht J; Sachs G S; Rosenbaum J F; Fava M
Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2000;12(3):137-40.
2000: Fava M; Rosenbaum J F; Hoog S L; Tepner R G; Kopp J B; Nilsson M E
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Journal of affective disorders 2000;59(2):119-26.
2000: Alpert J E; Mischoulon D; Nierenberg A A; Fava M
Nutrition and depression: focus on folate.
Nutrition (Burbank, Los Angeles County, Calif.) 2000;16(7-8):544-6.
2000: Fredman S J; Fava M; Kienke A S; White C N; Nierenberg A A; Rosenbaum J F
Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: a survey of current "next-step" practices.
The Journal of clinical psychiatry 2000;61(6):403-8.
2000: Mischoulon D; Nierenberg A A; Kizilbash L; Rosenbaum J F; Fava M
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2000;45(5):476-81.
2000: Michelson D; Fava M; Amsterdam J; Apter J; Londborg P; Tamura R; Tepner R G
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial.
The British journal of psychiatry : the journal of mental science 2000;176():363-8.
2000: Fava M; Vuolo R D; Wright E C; Nierenberg A A; Alpert J E; Rosenbaum J F
Fenfluramine challenge in unipolar depression with and without anger attacks.
Psychiatry research 2000;94(1):9-18.
2000: Matthews J D; Fava M
Risk of suicidality in depression with serotonergic antidepressants.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2000;12(1):43-50.
2000: Fava M; Rankin M A; Wright E C; Alpert J E; Nierenberg A A; Pava J; Rosenbaum J F
Anxiety disorders in major depression.
Comprehensive psychiatry 2000;41(2):97-102.
2000: Michelson D; Amsterdam J; Apter J; Fava M; Londborg P; Tamura R; Pagh L
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Psychoneuroendocrinology 2000;25(2):169-77.
2000: Fava M
Weight gain and antidepressants.
The Journal of clinical psychiatry 2000;61 Suppl 11():37-41.
2000: Fava M
Management of nonresponse and intolerance: switching strategies.
The Journal of clinical psychiatry 2000;61 Suppl 2():10-2.
2000: Fava M
New approaches to the treatment of refractory depression.
The Journal of clinical psychiatry 2000;61 Suppl 1():26-32.
2000: Baer L; Jacobs D G; Meszler-Reizes J; Blais M; Fava M; Kessler R; Magruder K; Murphy J; Kopans B; Cukor P; Leahy L; O'Laughlen J
Development of a brief screening instrument: the HANDS.
Psychotherapy and psychosomatics 2000;69(1):35-41.
1999: Sonawalla S B; Renshaw P F; Moore C M; Alpert J E; Nierenberg A A; Rosenbaum J F; Fava M
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
The American journal of psychiatry 1999;156(10):1638-40.
1999: Sonawalla S B; Spillmann M K; Kolsky A R; Alpert J E; Nierenberg A A; Rosenbaum J F; Fava M
Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
The Journal of clinical psychiatry 1999;60(9):580-3.
1999: Cannon B; Mulroy R; Otto M W; Rosenbaum J F; Fava M; Nierenberg A A
Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression.
Journal of affective disorders 1999;55(1):45-9.
1999: Fava M; Rosenbaum J F; Kolsky A R; Alpert J E; Nierenberg A A; Spillmann M; Moore C; Renshaw P; Bottiglieri T; Moroz G; Magni G
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder.
Journal of clinical psychopharmacology 1999;19(4):329-35.
1999: Alpert J E; Fava M; Uebelacker L A; Nierenberg A A; Pava J A; Worthington J J; Rosenbaum J F
Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder.
Biological psychiatry 1999;46(2):202-11.
1999: Nierenberg A A; Keefe B R; Leslie V C; Alpert J E; Pava J A; Worthington J J; Rosenbaum J F; Fava M
Residual symptoms in depressed patients who respond acutely to fluoxetine.
The Journal of clinical psychiatry 1999;60(4):221-5.
1999: Mischoulon D; Fava M; Rosenbaum J F
Strategies for augmentation of SSRI treatment: a survey of an academic psychopharmacology practice.
Harvard review of psychiatry 1999;6(6):322-6.
1999: Tedlow J; Leslie V; Keefe B R; Alpert J; Nierenberg A A; Rosenbaum J F; Fava M
Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks.
Journal of affective disorders 1999;52(1-3):217-23.
1999: Fava M; Rosenbaum J F
Anger attacks in patients with depression.
The Journal of clinical psychiatry 1999;60 Suppl 15():21-4.
1998: Fava M; Amsterdam J D; Deltito J A; Salzman C; Schwaller M; Dunner D L
A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1998;10(4):145-50.
1998: Tedlow J; Fava M; Uebelacker L; Nierenberg A A; Alpert J E; Rosenbaum J
Outcome definitions and predictors in depression.
Psychotherapy and psychosomatics 1998;67(4-5):266-70.
1998: Rosenbaum J F; Fava M; Hoog S L; Ascroft R C; Krebs W B
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Biological psychiatry 1998;44(2):77-87.
1998: Fava M
Depression with anger attacks.
The Journal of clinical psychiatry 1998;59 Suppl 18():18-22.
1998: Nierenberg A A; Alpert J E; Pava J; Rosenbaum J F; Fava M
Course and treatment of atypical depression.
The Journal of clinical psychiatry 1998;59 Suppl 18():5-9.
1998: Fava M; Rankin M A; Alpert J E; Nierenberg A A; Worthington J J
An open trial of oral sildenafilin antidepressant-induced sexual dysfunction.
Psychotherapy and psychosomatics 1998;67(6):328-31.
1998: Fava M; Rosenbaum J F
Anger attacks in depression.
Depression and anxiety 1998;8 Suppl 1():59-63.
1997: Fava M; Mulroy R; Alpert J; Nierenberg A A; Rosenbaum J F
Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.
The American journal of psychiatry 1997;154(12):1760-2.
1997: Fava M; Uebelacker L A; Alpert J E; Nierenberg A A; Pava J A; Rosenbaum J F
Major depressive subtypes and treatment response.
Biological psychiatry 1997;42(7):568-76.
1997: Fava M
[Anger outbursts in unipolar depressive disorders]
L'Encéphale 1997;23 Spec No 3():39-42.
1997: Fava M
Psychopharmacologic treatment of pathologic aggression.
The Psychiatric clinics of North America 1997;20(2):427-51.
1997: Alpert J E; Fava M
Nutrition and depression: the role of folate.
Nutrition reviews 1997;55(5):145-9.
1997: Alpert J E; Uebelacker L A; McLean N E; Nierenberg A A; Pava J A; Worthington J J; Tedlow J R; Rosenbaum J F; Fava M
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications.
Psychological medicine 1997;27(3):627-33.
1997: Fava M; Abraham M; Clancy-Colecchi K; Pava J A; Matthews J; Rosenbaum J F
Eating disorder symptomatology in major depression.
The Journal of nervous and mental disease 1997;185(3):140-4.
1997: Fava M; Borus J S; Alpert J E; Nierenberg A A; Rosenbaum J F; Bottiglieri T
Folate, vitamin B12, and homocysteine in major depressive disorder.
The American journal of psychiatry 1997;154(3):426-8.
1997: Spillmann M; Borus J S; Davidson K G; Worthington J J; Tedlow J R; Fava M
Sociodemographic predictors of response to antidepressant treatment.
International journal of psychiatry in medicine 1997;27(2):129-36.
1997: Fava M; Nierenberg A A; Quitkin F M; Zisook S; Pearlstein T; Stone A; Rosenbaum J F
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Psychopharmacology bulletin 1997;33(1):101-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Maurizio Fava

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Maurizio Fava (preview)

All Publications